NCT00116272View on ClinicalTrials.gov

Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project

CompletedOBSERVATIONAL
Enrollment

830

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Pregnancy
Interventions
DRUG

Etanercept

Pregnant women previously exposed to etanercept during the first trimester. Etanercept was not administered in this non-interventional study.

Trial Locations (1)

Unknown

Research Site, San Diego

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00116272 - Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project | Biotech Hunter | Biotech Hunter